Gene · 5313
Papers2,223
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,223
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Interferon-stimulated restriction factors in enterovirus infection: A review on the mechanisms and antiviral roles of shiftless (C19orf66). | Virology | 2027 | 42784970 | PubTator, text mining | PubMed |
| Case Report: Successful hematopoietic stem cell transplantation in pediatric pyruvate kinase deficiency: a single-center Asian case series demonstrating favorable outcomes. | Front Immunol | 2026 | 42707213 | PubTator, text mining | PubMed |
| Systemic removal of host restriction factors enables rapid, scalable virus production for cell culture-based vaccine development. | Front Bioeng Biotechnol | 2026 | 42698639 | PubTator, text mining | PubMed |
Severe Transfusion-Dependent Infantile Hemolytic Anemia Associated With a Novel Homozygous PKLR Variant of Uncertain Significance (c.1376C>G, p.Ala459Gly) and Coexisting G6PD Deficiency: A Case Report. | Cureus | 2026 | 42666890 | PubTator, text mining | PubMed |
| Therapeutic and Predicted Significance of PKLR in Patients With Cholangiocarcinoma. | Cancer Rep (Hoboken) | 2026 | 42599115 | PubTator, text mining | PubMed |
| Post-Treatment Persistent Erythrocytosis in Patients with Hodgkin Lymphoma: Molecular Mechanisms Underlying the Pathogenesis of Erythrocytosis. | Cancers (Basel) | 2026 | 42588719 | PubTator, text mining | PubMed |
| From structural insight to molecule: Integrative molecular simulations identify candidate pyruvate kinase activators. | PLoS One | 2026 | 42585268 | PubTator, text mining | PubMed |
| Circadian Regulation of Glucose Metabolism: Implications for Pathogenesis and Chronotherapy of Type 2 Diabetes. | Diabetology (Basel) | 2026 | 42583078 | PubTator, text mining | PubMed |
| PKR engages viral RNA and intron-retained host transcripts during poxvirus infection. | Cell Rep | 2026 | 42570237 | PubTator, text mining | PubMed |
| Case Report: A research on a case of hereditary spherocytosis with idiopathic pulmonary hemosiderosis. | Front Pediatr | 2026 | 42558654 | PubTator, text mining | PubMed |
| Retrospective dosimetric analysis and establishment of local typical dose values for otolaryngology scans performed with cone-beam CT. | Phys Med | 2026 | 42537432 | PubTator, text mining | PubMed |
| Leprosy in the Brazilian Amazon: Four Decades of Progress, Scientific Advances and Future Challenges. | Rev Soc Bras Med Trop | 2026 | 42524993 | PubTator, text mining | PubMed |
| Lost in translation: interferon-stimulated genes targeting flavivirus protein synthesis. | J Virol | 2026 | 42240343 | PubTator, text mining | PubMed |
| [Clinical analysis of six patients with pyruvate kinase deficiency caused by PKLR variants]. | Zhongguo Dang Dai Er Ke Za Zhi | 2026 | 42130359 | PubTator, text mining | PubMed |
| Expanding the PKLR mutation spectrum: discovery of two novel variants in two pediatric cases of pyruvate kinase deficiency. | Ann Hematol | 2026 | 42115487 | PubTator, text mining | PubMed |
| SNH-119014, a novel pyruvate kinase activator, enhances ATP production and reduces oxidative stress in erythroid cells from patients with β-thalassemia major. | Front Pharmacol | 2026 | 42110554 | PubTator, text mining | PubMed |
| Clinicohematological and Genetic Profile of Hereditary Spherocytosis in Children: An Experience From a North Indian Center. | J Pediatr Hematol Oncol | 2026 | 42054241 | PubTator, text mining | PubMed |
| Two Novel PKLR Variants in Pyruvate Kinase Deficiency: Insights From Clinical, Molecular and Functional Analysis. | Int J Lab Hematol | 2026 | 42049675 | PubTator, text mining | PubMed |
| Interplay of SLC33A1-dependent and -independent Golgi sialic acid O-acetylation in CASD1 catalysis. | Nat Commun | 2026 | 41917001 | PubTator, text mining | PubMed |
| Distinct metabolomic and proteomic signatures in Parkinson's disease patients with REM sleep behavior disorder. | Signal Transduct Target Ther | 2026 | 41912482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5313/papers